Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use Methylphenidate Hydrochloride Extended-Release Capsules safely and effectively. See full prescribing information for Methylphenidate Hydrochloride Extended-Release Capsules Methylphenidate Hydrochloride Extended-Release Capsules, for oral use, CII Initial U.S. Approval: 1955
Medication labelWhy this: Advisory · dailymed-prescription
Methylphenidate hydrochloride extended-release capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years and older [see Clinical Studies (14)]. Limitations of Use The use of methylphenidate hydrochloride extended-release capsules is not recommended in pediatric patients younger than 6 years of age because they had higher plasma exposure and a higher incidence of adverse reactions (e.g., weight loss) than patients 6 years and older at the same dosage [see Warnings and Precautions (5.7), Use in Specific Populations (8.4)].
- generic_name
- methylphenidate hydrochloride
- product_names
- Methylphenidate Hydrochloride
- ndc
- 42858-075, 42858-076, 42858-077, 42858-078, 42858-079, 42858-080, 42858-081, 42858-075-45, 42858-076-45, 42858-077-45, 42858-078-45, 42858-079-45, 42858-080-45, 42858-081-45
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en